Evidence map›Paper›PMID 26137046›Full record

ArticleOncology letters2015

Ovarian cancer transformation from adenocarcinoma to undifferentiated small cell carcinoma: A case report.

Zuo Ping Huang, Xing Jing Liu, Bin Xin Zou, Qian Shen, Ying Liu, Tao Zhou

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zuo Ping HuangDepartment of Oncology, The Affiliated Wujing Hospital of Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, Guangdong 510507, P.R. China.
Xing Jing LiuDepartment of Oncology, The Affiliated Wujing Hospital of Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, Guangdong 510507, P.R. China.
Bin Xin ZouDepartment of Oncology, The Affiliated Wujing Hospital of Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, Guangdong 510507, P.R. China.
Qian ShenDepartment of Oncology, The Affiliated Wujing Hospital of Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, Guangdong 510507, P.R. China.
Ying LiuDepartment of Oncology, The Affiliated Wujing Hospital of Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, Guangdong 510507, P.R. China.
Tao ZhouDepartment of Oncology, The Affiliated Wujing Hospital of Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, Guangdong 510507, P.R. China.
State Key Laboratory of Respiratory Disease · CNGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ovaries contain cells that have the capacity for regeneration and cancer stem cells (CSC) that are capable of differentiating aberrantly from the homeostatic controls. The histology of ovarian cancer does not usually change in a patient. However, CSCs are the origin of a number of tumors. CSCs are known to exist in ovarian carcinomas and the expression of CD44, c-Kit and CD133 has been identified in such carcinomas. This study presents the case of a patient diagnosed with ovarian cancer with an abdominal mass who underwent surgery, eight cycles of gemcitabine-paclitaxel chemotherapy and irradiation. Pathological examination indicated a transformation from adenocarcinoma to undifferentiated small cell carcinoma. The expression of CD133 changed from negative to positive in ovarian carcinomas. The present case indicates that any histological changes observed in ovarian neoplasms originate from neoplastic stem cells. In addition, this case demonstrates the importance of repeatedly assessing therapy by tumor biopsy throughout the course of ovarian cancer treatment.

Indexed as

adenocarcinomaovarian cancerundifferentiated small cell carcinoma

Identifiers

PMID26137046
PMCPMC4467345
OpenAlexW1971221596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.